{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:32:36Z","timestamp":1791405156224,"version":"4.3.3"},"reference-count":47,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,17]],"date-time":"2013-07-17T00:00:00Z","timestamp":1374019200000},"content-version":"vor","delay-in-days":1872,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunity"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1016\/j.immuni.2008.04.020","type":"journal-article","created":{"date-parts":[[2008,6,13]],"date-time":"2008-06-13T12:24:08Z","timestamp":1213359848000},"page":"822-832","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":305,"title":["Human Leukocyte Antigen Class I-Restricted Activation of CD8+ T Cells Provides the Immunogenetic Basis of a Systemic Drug Hypersensitivity"],"prefix":"10.1016","volume":"28","author":[{"given":"Diana","family":"Chessman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyudmila","family":"Kostenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tessa","family":"Lethborg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony W.","family":"Purcell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas A.","family":"Williamson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenjun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Kjer-Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole A.","family":"Mifsud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian D","family":"Tait","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhonda","family":"Holdsworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Coral Ann","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Nolan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Whitney A.","family":"Macdonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia K.","family":"Archbold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony D.","family":"Kellerher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debbie","family":"Marriott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Mallal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandvi","family":"Bharadwaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie","family":"Rossjohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"McCluskey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.immuni.2008.04.020_bib1","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.4049\/jimmunol.158.4.1660","article-title":"Polymorphism in the alpha 1 helix of the HLA-B heavy chain can have an overriding influence on peptide-binding specificity","volume":"158","author":"Barber","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/j.immuni.2008.04.020_bib2","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1146\/annurev.med.54.101601.152346","article-title":"The influence of HLA genotype on AIDS","volume":"54","author":"Carrington","year":"2003","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.immuni.2008.04.020_bib3","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.4049\/jimmunol.157.3.1000","article-title":"CTL recognition of an altered peptide associated with asparagine bond rearrangement. Implications for immunity and vaccine design","volume":"157","author":"Chen","year":"1996","journal-title":"J. Immunol."},{"key":"10.1016\/j.immuni.2008.04.020_bib4","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1107\/S0907444902015482","article-title":"The production, purification and crystallization of a soluble heterodimeric form of a highly selected T-cell receptor in its unliganded and liganded state","volume":"58","author":"Clements","year":"2002","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.immuni.2008.04.020_bib5","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1345\/aph.1E202","article-title":"Updated clinical risk factor analysis of suspected hypersensitivity reactions to Abacavir","volume":"38","author":"Cutrell","year":"2004","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.immuni.2008.04.020_bib6","doi-asserted-by":"crossref","first-page":"7401","DOI":"10.1128\/JVI.77.13.7401-7410.2003","article-title":"Ex vivo analysis of T-cell responses to Epstein-Barr virus-encoded oncogene latent membrane protein 1 reveals highly conserved epitope sequences in virus isolates from diverse geographic regions","volume":"77","author":"Duraiswamy","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.immuni.2008.04.020_bib7","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1084\/jem.20030121","article-title":"A new type of metal recognition by human T cells: Contact residues for peptide-independent bridging of T cell receptor and major histocompatibility complex by nickel","volume":"197","author":"Gamerdinger","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.immuni.2008.04.020_bib8","doi-asserted-by":"crossref","first-page":"3893","DOI":"10.4049\/jimmunol.177.6.3893","article-title":"Strong TCR conservation and altered T cell cross-reactivity characterize a B\u221757-restricted immune response in HIV-1 infection","volume":"177","author":"Gillespie","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.immuni.2008.04.020_bib9","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1002\/eji.200635896","article-title":"B\u22172707 differs in peptide specificity from B\u22172705 and B\u22172704 as much as from HLA-B27 subtypes not associated to spondyloarthritis","volume":"36","author":"Gomez","year":"2006","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.immuni.2008.04.020_bib10","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1084\/jem.180.2.739","article-title":"Recognition of carbohydrate by major histocompatibility complex class I-restricted, glycopeptide-specific cytotoxic T lymphocytes","volume":"180","author":"Haurum","year":"1994","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.immuni.2008.04.020_bib11","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.immuni.2007.05.015","article-title":"A structural and immunological basis for the role of human leukocyte antigen DQ8 in celiac disease","volume":"27","author":"Henderson","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2008.04.020_bib12","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/S0140-6736(02)08158-8","article-title":"Genetic variations in HLA-B region and hypersensitivity reactions to Abacavir","volume":"359","author":"Hetherington","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.immuni.2008.04.020_bib13","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/S0149-2918(01)80132-6","article-title":"Hypersensitivity reactions during therapy with the nucleoside reverse transcriptase inhibitor Abacavir","volume":"23","author":"Hetherington","year":"2001","journal-title":"Clin. Ther."},{"key":"10.1016\/j.immuni.2008.04.020_bib14","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/360434a0","article-title":"Molecular analysis of the association of HLA-B53 and resistance to severe malaria","volume":"360","author":"Hill","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2008.04.020_bib15","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1517\/phgs.5.2.203.27481","article-title":"Association of genetic variations in HLA-B region with hypersensitivity to Abacavir in some, but not all, populations","volume":"5","author":"Hughes","year":"2004","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.immuni.2008.04.020_bib16","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/00008571-200406000-00002","article-title":"Cost-effectiveness analysis of HLA B\u22175701 genotyping in preventing Abacavir hypersensitivity","volume":"14","author":"Hughes","year":"2004","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.immuni.2008.04.020_bib17","doi-asserted-by":"crossref","first-page":"47844","DOI":"10.1074\/jbc.M206392200","article-title":"HLA-B27 subtypes differentially associated with disease exhibit subtle structural alterations","volume":"277","author":"Hulsmeyer","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.immuni.2008.04.020_bib18","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.jaci.2004.12.1140","article-title":"Intracellular cytokines may model immunoregulation of Abacavir hypersensitivity in HIV-infected subjects","volume":"115","author":"King","year":"2005","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.immuni.2008.04.020_bib19","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/s002510050355","article-title":"Residue 116 determines the C-terminal anchor residue of HLA-B\u22173501 and -B\u22175101 binding peptides but does not explain the general affinity difference","volume":"47","author":"Kubo","year":"1998","journal-title":"Immunogenetics"},{"key":"10.1016\/j.immuni.2008.04.020_bib20","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.4049\/jimmunol.166.5.3549","article-title":"HLA-DP allele-specific T cell responses to beryllium account for DP-associated susceptibility to chronic beryllium disease","volume":"166","author":"Lombardi","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.immuni.2008.04.020_bib21","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1084\/jem.20021762","article-title":"Components of the ligand for a Ni++ reactive human T cell clone","volume":"197","author":"Lu","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.immuni.2008.04.020_bib22","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1084\/jem.20030066","article-title":"A naturally selected dimorphism within the HLA-B44 supertype alters class I structure, peptide repertoire, and T cell recognition","volume":"198","author":"Macdonald","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.immuni.2008.04.020_bib23","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0140-6736(02)07873-X","article-title":"Association between presence of HLA-B\u22175701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor Abacavir","volume":"359","author":"Mallal","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.immuni.2008.04.020_bib24","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1056\/NEJMoa0706135","article-title":"HLA-B\u22175701 screening for hypersensitivity to Abacavir (Study CNA106030)","volume":"358","author":"Mallal","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.immuni.2008.04.020_bib25","series-title":"Fundamental Immunology","article-title":"Major histocompatibility complex (MHC) molecules: Structure, function, and genetics","author":"Margulies","year":"2008"},{"key":"10.1016\/j.immuni.2008.04.020_bib26","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1097\/QAD.0b013e3280119579","article-title":"Immune responses to Abacavir in antigen-presenting cells from hypersensitive patients","volume":"21","author":"Martin","year":"2007","journal-title":"AIDS"},{"key":"10.1016\/j.immuni.2008.04.020_bib27","doi-asserted-by":"crossref","first-page":"4180","DOI":"10.1073\/pnas.0307067101","article-title":"Predisposition to Abacavir hypersensitivity conferred by HLA-B\u22175701 and a haplotypic Hsp70-Hom variant","volume":"101","author":"Martin","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2008.04.020_bib28","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.coi.2004.07.016","article-title":"TAP genes and immunity","volume":"16","author":"McCluskey","year":"2004","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.immuni.2008.04.020_bib29","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1600-6143.2007.02044.x","article-title":"Immunodominance hierarchies and gender bias in direct T(CD8)-cell alloreactivity","volume":"8","author":"Mifsud","year":"2008","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.immuni.2008.04.020_bib30","first-page":"1269","article-title":"Genetic control of hapten-reactive helper T-cell responses and its implications for the generation of augmented antitumor cytotoxic responses","volume":"74","author":"Mizushima","year":"1985","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.immuni.2008.04.020_bib31","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/nm0698-713","article-title":"Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease","volume":"4","author":"Molberg","year":"1998","journal-title":"Nat. Med."},{"key":"10.1016\/j.immuni.2008.04.020_bib32","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S1074-7613(00)80558-0","article-title":"HLA-B27-restricted antigen presentation in the absence of tapasin reveals polymorphism in mechanisms of HLA class I peptide loading","volume":"8","author":"Peh","year":"1998","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2008.04.020_bib33","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1097\/00002030-200211080-00017","article-title":"Utility of patch testing in patients with hypersensitivity syndromes associated with Abacavir","volume":"16","author":"Phillips","year":"2002","journal-title":"AIDS"},{"key":"10.1016\/j.immuni.2008.04.020_bib34","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1097\/01.aids.0000171414.99409.fb","article-title":"Clinical and immunogenetic correlates of Abacavir hypersensitivity","volume":"19","author":"Phillips","year":"2005","journal-title":"AIDS"},{"key":"10.1016\/j.immuni.2008.04.020_bib35","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.4049\/jimmunol.160.3.1085","article-title":"Avoidance of self-reactivity results in skewed CTL responses to rare components of synthetic immunogens","volume":"160","author":"Purcell","year":"1998","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.immuni.2008.04.020_bib36","doi-asserted-by":"crossref","first-page":"28749","DOI":"10.1074\/jbc.M204155200","article-title":"Differential association of HLA-B\u22172705 and B\u22172709 to ankylosing spondylitis correlates with limited peptide subsets but not with altered cell surface stability","volume":"277","author":"Ramos","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.immuni.2008.04.020_bib37","doi-asserted-by":"crossref","first-page":"5150","DOI":"10.1021\/bi0121858","article-title":"Insights into the molecular mechanism of inhibition and drug resistance for HIV-1 RT with carbovir triphosphate","volume":"41","author":"Ray","year":"2002","journal-title":"Biochemistry"},{"key":"10.1016\/j.immuni.2008.04.020_bib38","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1126\/science.8105536","article-title":"HLA-DPB1 glutamate 69: A genetic marker of beryllium disease","volume":"262","author":"Richeldi","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.immuni.2008.04.020_bib39","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1073\/pnas.85.1.227","article-title":"Transfer and expression of three cloned human non-HLA-A,B,C class I major histocompatibility complex genes in mutant lymphoblastoid cells","volume":"85","author":"Shimizu","year":"1988","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2008.04.020_bib40","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1084\/jem.183.2.527","article-title":"An HLA-A2-restricted tyrosinase antigen on melanoma cells results from posttranslational modification and suggests a novel pathway for processing of membrane proteins","volume":"183","author":"Skipper","year":"1996","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.immuni.2008.04.020_bib41","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.4049\/jimmunol.175.4.2459","article-title":"Structures of three HIV-1 HLA-B\u22175703-peptide complexes and identification of related HLAs potentially associated with long-term nonprogression","volume":"175","author":"Stewart-Jones","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.immuni.2008.04.020_bib42","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/jac\/dkm243","article-title":"Incidence of Abacavir hypersensitivity and its relationship with HLA-B\u22175701 in HIV-infected patients in Taiwan","volume":"60","author":"Sun","year":"2007","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.immuni.2008.04.020_bib43","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1034\/j.1399-0039.2002.590103.x","article-title":"The cell biology of MHC class I antigen presentation","volume":"59","author":"Williams","year":"2002","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.immuni.2008.04.020_bib44","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S1074-7613(02)00304-7","article-title":"Optimization of the MHC class I peptide cargo is dependent on tapasin","volume":"16","author":"Williams","year":"2002","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2008.04.020_bib45","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1128\/JVI.01580-06","article-title":"Mutually exclusive T-cell receptor induction and differential susceptibility to human immunodeficiency virus type 1 mutational escape associated with a two-amino-acid difference between HLA class I subtypes","volume":"81","author":"Yu","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.immuni.2008.04.020_bib46","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.4049\/jimmunol.148.6.1941","article-title":"The HLA-A,B \u201cnegative\u201d mutant cell line C1R expresses a novel HLA-B35 allele, which also has a point mutation in the translation initiation codon","volume":"148","author":"Zemmour","year":"1992","journal-title":"J. Immunol."},{"key":"10.1016\/j.immuni.2008.04.020_bib47","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1084\/jem.20031680","article-title":"Natural HLA class I polymorphism controls the pathway of antigen presentation and susceptibility to viral evasion","volume":"200","author":"Zernich","year":"2004","journal-title":"J. Exp. Med."}],"container-title":["Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1074761308002422?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1074761308002422?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T07:53:17Z","timestamp":1761033197000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1074761308002422"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":47,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["S1074761308002422"],"URL":"https:\/\/doi.org\/10.1016\/j.immuni.2008.04.020","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1116512.572544","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.1116512.569084","asserted-by":"object"}]},"ISSN":["1074-7613"],"issn-type":[{"value":"1074-7613","type":"print"}],"subject":[],"published":{"date-parts":[[2008,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Human Leukocyte Antigen Class I-Restricted Activation of CD8+ T Cells Provides the Immunogenetic Basis of a Systemic Drug Hypersensitivity","name":"articletitle","label":"Article Title"},{"value":"Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.immuni.2008.04.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}